Trial Profile
A double-blind phase I trial comparing fast-acting insulin with insulin aspart and regular insulin in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Aug 2011
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 10 Aug 2011 New trial record
- 15 Jun 2011 Results will be presented at the 2nd Annual Protein Formulation Development Forum, the 71st Scientific Sessions of the American Diabetes Association and the 38th Annual Meeting of the Controlled Release Society, according to an Adocia media release.